SERPING1 and angioedema: Recent literature reports support the hypothesis that a large proportion of SERPING1 missense variants cause the disease through dominant-negative mechanisms, which has been crucial in the development of new treatments for hereditary angioedema, including antisense oligonucleotide treatment and gene therapies [44, 53, 54].